1 Program for Immunology and Immunotherapy, CIMA. Universidad de Navarra, Pamplona, Spain. imelero@unav.es.
2 Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. imelero@unav.es.
3 Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Madrid, Spain. imelero@unav.es.
4 Departments of Immunology and Oncology, Clínica Universidad de Navarra, Pamplona, Spain. imelero@unav.es.
5 Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain. imelero@unav.es.
6 Program for Immunology and Immunotherapy, CIMA. Universidad de Navarra, Pamplona, Spain.
7 Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.
8 Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain.
9 Cell Therapy, Stem Cells and Tissue Group, Biobizkaia Health Research Institute, Barakaldo, Spain.
10 Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain.
11 Program for Immunology and Immunotherapy, CIMA. Universidad de Navarra, Pamplona, Spain. maite.alvarezrodriguez@bio-bizkaia.eus.
12 Navarra Institute for Health Research (IdiSNA), Pamplona, Spain. maite.alvarezrodriguez@bio-bizkaia.eus.
13 Red de Inmunoterapia del Cáncer (REINCA), Madrid, Spain. maite.alvarezrodriguez@bio-bizkaia.eus.
14 Cell Therapy, Stem Cells and Tissue Group, Biobizkaia Health Research Institute, Barakaldo, Spain. maite.alvarezrodriguez@bio-bizkaia.eus.
15 Advanced Therapies Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain. maite.alvarezrodriguez@bio-bizkaia.eus.